HCW Biologics Inc. (HCWB)
NASDAQ: HCWB · Real-Time Price · USD
0.710
-0.238 (-25.08%)
At close: Nov 21, 2024, 4:00 PM
0.735
+0.025 (3.58%)
After-hours: Nov 21, 2024, 5:03 PM EST
HCW Biologics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 27 | 44 | 69 | 83 | - | - |
| Market Cap Growth | -70.11% | -35.84% | -17.13% | - | - | - |
| Enterprise Value | 48 | 39 | 49 | 43 | - | - |
| Last Close Price | 0.95 | 1.23 | 1.91 | 2.32 | - | - |
| PS Ratio | 10.25 | 15.51 | 10.22 | - | - | - |
| PB Ratio | -2.05 | 3.27 | 1.84 | 1.62 | - | - |
| P/TBV Ratio | - | 3.27 | 1.84 | 1.62 | - | - |
| EV/Sales Ratio | 13.59 | 13.85 | 7.31 | - | - | - |
| Debt / Equity Ratio | -1.27 | 0.48 | 0.18 | - | 0.04 | - |
| Asset Turnover | 0.11 | 0.08 | 0.13 | - | 0.32 | - |
| Quick Ratio | 0.07 | 0.59 | 10.99 | 15.87 | 10.94 | 6.90 |
| Current Ratio | 0.09 | 0.73 | 11.52 | 17.44 | 12.14 | 7.53 |
| Return on Equity (ROE) | -537.24% | -98.23% | -33.63% | -39.22% | -49.60% | - |
| Return on Assets (ROA) | -74.57% | -42.68% | -18.79% | -24.25% | -28.59% | - |
| Return on Capital (ROIC) | -140.08% | -50.27% | -19.79% | -25.26% | -30.38% | - |
| Earnings Yield | -104.20% | -56.72% | -21.69% | -15.52% | - | - |
| FCF Yield | -65.16% | -30.08% | -13.30% | - | - |
| Buyback Yield / Dilution | -5.37% | -0.30% | -90.84% | -296.07% | -10.56% | - |
| Total Shareholder Return | -5.37% | -0.30% | -90.84% | -296.07% | -10.56% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.